We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MAXIS:MYXMaxis Bhd. Analysis

Data as of 2026-03-15 - not real-time

MYR 3.81

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Maxis shares are trading at MYR 3.81, just above the 20‑day SMA of 3.86 and marginally below the 50‑day SMA of 3.87, indicating a neutral to slightly bearish short‑term bias. The RSI of 45 and a bearish MACD histogram reinforce this cautious stance, while the price sits comfortably between the identified support of 3.72 and resistance of 3.98. Valuation metrics show a PE of 19.05, higher than the telecom industry average of 17.77, and a lofty P/B of 4.85, suggesting the stock is not cheap on a pure multiple basis. However, the discounted cash‑flow model estimates a fair value of MYR 3.74, only a few cents below the current price, and analysts forecast a modest upside of roughly 7 % with a mean target of MYR 4.08.
Fundamentally, Maxis delivers solid profitability with a ROE of 26 % and a healthy operating cash flow of MYR 3.58 bn, but its capital structure is strained, reflected by a debt‑to‑equity ratio of 152 % and a high dividend payout ratio of 85 %. The attractive 5.77 % dividend yield is offset by sustainability concerns given the leverage and payout level. Overall, the market sentiment is bullish (Fear‑Greed Index 72.9), yet technical signals remain neutral, positioning Maxis as a fair‑valued, value‑oriented play with moderate upside potential.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD histogram
  • RSI near neutral territory
  • Price close to support level

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Analyst price targets indicating ~7% upside
  • Strong ROE and cash flow generation
  • Attractive dividend yield despite sustainability concerns

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Stable telecom sector fundamentals
  • High leverage and elevated payout ratio
  • Consistent cash flow but limited growth prospects

Key Metrics & Analysis

Financial Health

Revenue Growth3.80%
Profit Margin14.68%
P/E Ratio19.1
ROE25.90%
ROA6.01%
Debt/Equity152.74
P/B Ratio4.9
Op. Cash FlowMYR3.6B
Free Cash FlowMYR2.4B
Industry P/E17.8

Technical Analysis

TrendNeutral
RSI45.0
SupportMYR 3.72
ResistanceMYR 3.98
MA 20MYR 3.86
MA 50MYR 3.87
MA 200MYR 3.75
MACDBearish
VolumeStable
Fear & Greed Index72.88

Valuation

Fair ValueMYR 3.74
Target PriceMYR 4.08
Upside/Downside6.98%
GradeFair
TypeValue
Dividend Yield5.77%

Risk Assessment

Beta0.20
Volatility21.01%
Sector RiskLow
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.